Tag: Closely

Categories
Health

UK carefully watched with its vaccine program and surge in circumstances

UK closely watched with its vaccine program and surge in cases

New Yorkers, 12 and older, will be vaccinated on June 13, 2021 at the St. Anthony of Padua Roman Catholic Church in the Bronx of New York City, United States.

Tayfun Coskun | Anadolu Agency | Getty Images

LONDON – The UK has one of the highest Covid-19 vaccination rates in the world but is seeing a new surge in coronavirus cases, largely due to the Delta variant, which originally came from India.

Experts say the latest UK data will be given a lot of attention as it could be an editorial for others. And there are fears that where the UK is now performing, others – like the US – may follow suit.

“All eyes (are) on the UK Covid trends,” said Kallum Pickering, Senior Economist and Director of Berenberg Bank, in a statement on Tuesday.

“Great Britain, with its high vaccination rate but an increasing number of infections recorded daily, has developed into a test case for whether a mass vaccination against SARS-CoV-2 can bring” [an] End of the repeated cycles of lockdowns and other harsh social distancing protocols that have had a devastating impact on the global economy since the pandemic began in early 2019, “he said.

Pickering noted that medical data suggests that the UK’s high vaccination rate has severely weakened the link between registered Covid infections and complications from the disease, which supports the bank’s claim that “Britain can weather the new wave of infections without having to tighten the restrictions and “with only limited economic damage.”

Pickering said the data indicated that this wave of infections was different from the previous ones, with the number of registered infections increasing more slowly than the previous wave, and that despite the increase in cases, there has been no clear increase in deaths.

Second, he found that new admissions to the hospital had risen less than the registered infections – and much less than during the winter wave.

Reopening on track?

Deutsche Bank research strategist Jim Reid noted on Wednesday that while there is “persistent concern” about the spread of the Delta variant, “the only good news is that the age distribution of cases in the latest wave has moved significantly lower compared to the previous “. Waves.”

Younger age groups are affected by the virus much less often than older people. But the longer the boys remain unvaccinated or partially vaccinated, the virus is allowed to spread and possibly more variants can emerge.

So far, the vaccines have been shown to be resistant to new variants and remain largely effective in preventing serious Covid-19 for fully vaccinated people. An analysis published by Public Health England last Monday found that two doses of the Pfizer BioNTech or AstraZeneca Covid-19 vaccines were highly effective against hospitalizations from the Delta variant.

In order to fully vaccinate more people, the UK government has postponed the lifting of the remaining Covid restrictions in England until July 19. She has insisted that the lifting of restrictions on that date is still on track despite the proliferation of the Delta variant.

“The risk that the reopening could be reversed remains low,” said Pickering von Berenberg.

“The UK is far from where medical capacity could be stretched to the point where new restrictions would be required,” he noted, adding that the continued rapid introduction of vaccines in the coming weeks could even lead to that the daily infections run on a plateau before it falls afterwards.

“While the pandemic is far from over and potential new variants that render the current generation of vaccines ineffective are a serious risk, recent virus and vaccine developments support our positive economic outlook for the UK and other advanced economies,” he said.

Winter wave?

What will come later this year when the flu season starts is more uncertain. England’s chief medical officer warned last week that the coming winter will continue to be difficult for the country’s health system despite the country’s successful coronavirus vaccination program.

In a speech to the NHS Confederation last Thursday, England Chief Medical Officer Chris Whitty said the current wave of Covid infections due to the Delta variant is likely to be followed by a further surge in winter.

Covid-19 “didn’t bring us its final surprise and there will be a few more [variants] over the next period, “he said, according to Sky News. He added that it would likely be five years before there are vaccines that could highly” hold the line “against a range of coronavirus variants.

And until then, new vaccination programs and booster vaccinations are necessary. Some countries, like the US and UK, have already signaled that they could introduce Covid-19 booster vaccinations within a year, but pressure is mounting on governments to mobilize refresher programs – not an easy task given the ongoing uncertainties surrounding the pandemic , Vaccines and variants.

Categories
Health

WHO is carefully monitoring 10 Covid variants as virus mutates world wide

WHO is closely monitoring 10 Covid variants as virus mutates around the world

Mukesh Bhardwaj cries as he sits next to his wife, who is receiving free oxygen support for people with respiratory problems, outside a Gurudwara (Sikh temple) amid the spread of coronavirus disease (COVID-19) in Ghaziabad, India. May 3, 2021.

Adnan Abidi | Reuters

The World Health Organization is tracking 10 variants of coronavirus “of concern” or “worrying” around the world, including two that were first discovered in the US and one triple mutant that is wreaking havoc in India as a potential global threat to the world public health.

New strains of Covid-19 emerge every day as the virus continues to mutate, but only a handful make the WHO official watch list an “variant of interest” or the more serious term “variant of concern” which is commonly defined as a mutated strain that is more contagious, more deadly, and more resistant to current vaccines and treatments.

The organization has identified three strains as variants of concern: B.1.1.7, which was first detected in the UK and is currently the most common strain in the US; B. 1.351, detected for the first time in South Africa, and the P.1 variant, detected for the first time in Brazil.

An interesting variant is the B.1617 variant or the triple mutated strain that was first found in India. However, WHO technical lead on Covid-19, Maria Van Kerkhove, said more studies are needed to fully understand its significance.

“There are actually a number of virus variants that are being discovered around the world and that we must all properly assess,” said Van Kerkhove. Scientists are studying how much each variant circulates in local areas, whether the mutations change the severity or transmission of the disease, and other factors, before being classified as a new public health threat.

“The information comes quickly and furiously,” she said. “There are new variants being identified and reported every day, not all of which are important.”

Other variants classified as variants of interest include B.1525, which was first detected in the UK and Nigeria; B.1427 / B.1429, recorded for the first time in the USA; P.2, first discovered in Brazil; P.3, first discovered in Japan and the Philippines; S477N, first detected in the USA, and B.1.616, first detected in France.

Van Kerkhove said the classifications are determined, at least in part, by sequencing capabilities, which vary from country to country. “It’s been really sketchy so far,” she said.

She said the agency is also viewing local epidemiologists as an extension of the agency’s “eyes and ears” to better understand the local situation and identify other potentially dangerous variants.

“It is important that we have the right discussions to determine which ones are important to the public health value. This means that doing so changes our ability to use public health social measures or any of our medical countermeasures.” , she said.

“We’re getting the right people together in the room to discuss what these mutations mean,” she said. “We need the global community to work together, and they are.”

The Centers for Disease Control and Prevention also have a list of four variants of interest and five variants of concern that is similar to the WHO list, although the CDC mainly focuses on variants that are causing new outbreaks in the United States.

Van Kerkhove said a number of countries “have some worrying trends, some worrying signs of rising case numbers, increasing hospitalization rates and increasing ICU rates in countries that do not yet have access to the vaccine and that have not achieved the required levels of coverage.” really having these effects on serious illness and death and transmission. “

Categories
Politics

Prime Official Warned That Covid Vaccine Plant Needed to Be ‘Monitored Intently’

Top Official Warned That Covid Vaccine Plant Had to Be ‘Monitored Closely’

Mr de Notaristefani, a former executive at two large pharmaceutical companies, cited “significant” staffing problems and wrote that plans to increase staff were “insufficient to enable the company to produce at the required speed”.

He also noted that audits by the FDA and individual companies hiring Emergent “highlighted the need for extensive staff training and strengthening the quality function.”

Nevertheless, he wrote: “The organization has the necessary experience / competence” to enlarge its production. He wrote that “the management is knowledgeable and appears confident” and that with adequate government oversight, “risks can be mitigated”.

At the time of the visit, Emergent was also planning to manufacture a third Covid-19 vaccine developed by Novavax. Since then, this company has partnered with another manufacturer. “Offloading the Novavax program to another facility will also help ease the burden on Emergent Bayview,” wrote de Notaristefani.

Emergent is a longtime federal entrepreneur in the biological defense field. Sales of its anthrax vaccines accounted for nearly half of Strategic National Stockpile’s annual budget of half a billion dollars for most of the past decade, The Times reported last month. This left the government with less money on items needed during a pandemic, and last year the lack of basic health care in inventory became a symbol of the government’s botched coronavirus response.

Although the original federal contract for the Baltimore plant required Emergent to demonstrate large-scale manufacture of a pandemic influenza vaccine – designated by health officials as a pressure test of its capabilities – Emergent had yet to do so, The Times reported Tuesday. The company risked default on the original contract, which set a deadline of June 2020. The company also has separate agreements with the two vaccine makers valued at more than $ 875 million.

In an effort to solve the factory’s problems, federal officials have simplified Emergent’s mission by limiting themselves to just making Johnson & Johnson’s vaccine and forcing AstraZeneca to relocate their production lines. Johnson & Johnson now also maintains direct control of manufacturing, although the workforce at the facility in southeast Baltimore remains with Emergent.